Byung-Jae Lee
Algemeen Directeur bij FLASK CO., LTD.
Vermogen: - $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Byung-Jae Lee
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Electronic Production Equipment | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Byung-Jae Lee via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
GEMVAX&KAEL CO.,LTD. | Industrial Machinery | Chief Executive Officer | |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Pharmaceuticals: Major | Chief Executive Officer | |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Biotechnology | Chief Executive Officer | |
Hanyang University | College/University | Doctorate Degree | |
Gem & Co. /KR/
Gem & Co. /KR/ Investment ManagersFinance Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea. | Investment Managers | Chief Executive Officer | |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Pharmaceuticals: Major | Director/Board Member | |
Gemvax USA, Inc. | Chief Executive Officer | ||
SAMSUNG PHARM. CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
PONYLINK CO., LTD. | Apparel/Footwear Retail | Chief Executive Officer | |
Teloid, Inc. | Chief Executive Officer | ||
Korea University | College/University | Graduate Degree |
Statistieken
Internationaal
Zuid-Korea | 11 |
Verenigde Staten | 3 |
Noorwegen | 2 |
Zweden | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Electronic Technology | 2 |
Process Industries | 2 |
Producer Manufacturing | 2 |
Operationeel
Director/Board Member | 14 |
Chief Executive Officer | 11 |
Graduate Degree | 2 |
Undergraduate Degree | 2 |
Independent Dir/Board Member | 2 |
Sterkste connecties
Insiders | |
---|---|
Sang-Jae Kim | 14 |
Gi-Cheol Park | 2 |
In-Sook Kim | 1 |
Seung-Yeon Kim | 1 |
Sung-Jin Park | 1 |
Soo-Ah Yoon | 1 |
Se-Jun Park | 1 |
Styslinger Sarah | 1 |
- Beurs
- Insiders
- Byung-Jae Lee
- Bedrijfsconnecties